Profile data is unavailable for this security.
About the company
Cowealth Medical China Co Ltd is a China-based company mainly engaged in the wholesale of medical equipment products. The Company's businesses include in-vitro diagnostic product intensive business and medical product distribution business. The in-vitro diagnostic product intensive business is engaged in the wholesale business of in vitro diagnostic products, mainly including immunodiagnosis, biochemical diagnosis, clinical testing, real-time testing, molecular diagnosis, pathology, microbiological testing, blood source safety monitoring and others. The medical product distribution business mainly includes the wholesale sales of equipment in the field of swelling, immunodiagnosis and biochemical diagnosis. The Company mainly operates its business in the domestic market.
- Revenue in CNY (TTM)1.06bn
- Net income in CNY45.10m
- Incorporated2000
- Employees240.00
- LocationCowealth Medical China Co Ltd1F, Guangqi Building, 456 Hongcao RoadSHANGHAI 200233ChinaCHN
- Phone+86 2 160378999
- Fax+86 2 164959700
- Websitehttps://ch.cowealth.com/En/index.html
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Guangzhou Jet Bio-Filtration Co Ltd | 487.09m | 51.76m | 1.62bn | 1.09k | 30.30 | 1.40 | -- | 3.32 | 0.3805 | 0.3805 | 3.62 | 8.26 | 0.3051 | 3.08 | 5.08 | 446,463.00 | 3.26 | 9.35 | 3.48 | 10.39 | 31.00 | 36.76 | 10.69 | 17.89 | 6.86 | 9.15 | 0.2319 | 29.64 | -24.06 | 17.42 | -60.34 | -8.02 | 47.32 | -- |
| Allgens Medical Technology Co Ltd | 226.03m | 42.66m | 1.83bn | 202.00 | 42.26 | 1.29 | -- | 8.11 | 0.3199 | 0.3199 | 1.70 | 10.47 | 0.151 | 1.42 | 3.98 | 1,118,950.00 | 2.78 | 7.62 | 2.90 | 8.30 | 80.57 | 83.60 | 18.40 | 39.05 | 35.91 | -- | 0.0354 | 5.25 | -7.68 | 12.86 | -43.04 | 10.46 | -26.12 | -- |
| Nanjing Medlander Medical Tech Co Ltd | 336.04m | 93.72m | 2.20bn | 481.00 | 23.53 | 1.60 | -- | 6.55 | 0.9354 | 0.9354 | 3.37 | 13.78 | 0.2194 | 1.88 | 18.91 | 698,624.50 | 6.35 | -- | 6.93 | -- | 73.32 | -- | 28.95 | -- | 8.63 | -- | 0.0104 | -- | -9.57 | -- | -26.19 | -- | -- | -- |
| Cowealth Medical China Co Ltd | 1.06bn | 45.10m | 2.40bn | 240.00 | 53.14 | 2.04 | -- | 2.25 | 0.1133 | 0.1133 | 2.67 | 2.95 | 0.7144 | 4.20 | 1.38 | 4,433,473.00 | 3.03 | 5.80 | 3.78 | 8.09 | 20.55 | 20.74 | 4.24 | 6.14 | 3.68 | -- | 0.0986 | 23.89 | -14.62 | 3.85 | -42.96 | -6.75 | 32.85 | -- |
| Nanjing Vishee Medical Technology Co Ltd | 454.35m | 127.93m | 3.03bn | 700.00 | 23.56 | 1.83 | -- | 6.67 | 1.88 | 1.88 | 6.66 | 24.20 | 0.2583 | 3.38 | 15.91 | 649,077.10 | 7.27 | 10.27 | 7.85 | 11.43 | 70.28 | 73.26 | 28.16 | 33.99 | 10.18 | -- | 0.00 | 47.57 | 43.72 | 17.34 | 45.22 | 16.55 | 26.69 | -- |
| Shanghai Kindly Enterprise Dev Gp Co Ltd | 2.34bn | 206.32m | 3.24bn | 4.23k | 15.51 | 1.31 | -- | 1.39 | 0.4734 | 0.4734 | 5.36 | 5.62 | 0.5595 | 3.80 | 2.35 | 552,556.30 | 5.74 | 8.09 | 9.36 | 16.09 | 30.50 | 36.01 | 10.27 | 12.53 | 1.26 | -- | 0.2248 | 26.55 | -21.36 | 11.08 | -25.92 | 9.44 | 4.85 | 1.30 |
Data as of May 28 2024. Currency figures normalised to Cowealth Medical China Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
0.39%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Hongde Fund Management Co., Ltd.as of 31 Dec 2023 | 339.10k | 0.19% |
| Gfund Management Co., Ltd.as of 31 Dec 2023 | 219.30k | 0.12% |
| China Fund Management Co., Ltd.as of 31 Dec 2023 | 41.30k | 0.02% |
| Guolian Fund Management Co. Ltd.as of 31 Dec 2023 | 34.70k | 0.02% |
| GF Fund Management Co., Ltd.as of 31 Dec 2023 | 24.10k | 0.01% |
| Manulife TEDA Fund Management Co., Ltd.as of 31 Dec 2023 | 18.60k | 0.01% |
| Penghua Fund Management Co., Ltd.as of 31 Dec 2023 | 9.18k | 0.01% |
| China Universal Asset Management Co., Ltd.as of 31 Dec 2023 | 4.40k | 0.00% |
| New China Fund Management Co., Ltd.as of 31 Dec 2023 | 2.20k | 0.00% |
| Guotai Asset Management Co., Ltd.as of 31 Dec 2023 | 1.00k | 0.00% |
More ▼
Data from 31 Dec 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
